We are XEOS

Our goal is to eliminate the risk of resurgery through smarter specimen imaging. Therefore, we are focused on improving outcomes in surgical oncology through innovations in intraoperative imaging.

Founded in Ghent in 2019, we have grown to become a team of bright and passionate minds, revolutionizing the performance of specimen imaging and supporting surgical confidence.

We host a wealth of competence in the medical device industry, medical image reconstruction and processing, and fundamental scientific research. We hold a strong track record of inhouse PET & CT design. We are adepts of molecular imaging.

We are XEOS
The power of molecular imaging

The power of molecular imaging

XEOS wants to tackle the limitations of today’s available imaging techniques applied in surgical oncology, by using the transformative power of molecular Imaging intra-operatively.

XEOS AURA specimen imager brings a new imaging system that uses high-resolution Positron Emission tomography (PET) with X-ray Computed Tomography (CT) imaging. This method relies on the high sensitivity of PET radiotracer uptake for detecting metabolically active tissue and on the delineation of the anatomical margins of the specimen using CT.

This approach is transforming specimen imaging, allowing surgical oncologists to operate with more clarity and confidence.

Discover AURA 10

Xeos values

Excellence

We have the ambition to surpass ordinary standards. Therefore, we deliver solutions and services with an outstanding fit for intended purpose, inherently safe and performant. With evident appreciation for aesthetics and taste.

Dedication

We are committed to being wholeheartedly devoted to the company, out of own volition and motivation. Willingly committing time and energy, we create an intellectual and emotional bond to our mission and vision.

Agility

We aim to move and adapt efficiently and effectively. While integrating skills such as coordination speed, alertness, flexibility, vigilance and endurance, we enable optimal responsiveness to continuously changing situations.

Transparency

We do things in an open way without secrecy, both internally and externally, between employees and towards suppliers and customers. We communicate with a clear voice to ensure our message is understood and honest feedback is received.

Meet the team

Vincent Keereman
Chief Executive Officer, co-founder, Board Member
Jakob Roelandt
Chief Technical Officer
Eva Roos
Chief Operations Officer
Elke Claeys
Chief Commercial Officer
Guy Albalancy
Sales Director, US
Alexander Allemeersch
Market Access Specialist
Philine Blomme
Head of Clinical Marketing
Phebe De Coene
Data & Quality Manager
Hagen Derde
Head of Sales EU
Lieze De Witte
Administrative Assistant
Stéphanie Droesbeke
HR Manager / IPA
Dennis Goossens
Manufacturing Engineer
Anneleen Kiekens
Clinical Scientist
Christel Lambrechts
Application Specialist
Luna Maris
Research Engineer
Petar Petrov
Senior Software Engineer
Cristian Pinelo
Service Engineer
Katyayani Sharma
Clinical Scientist
Agnieszka Swiatek
QARA Manager
Leen Van de Sande
Senior Clinical Scientist / Radiation Protection Officer
Kato Van De Wielle
Application specialist
Kaat Vandorpe
Clinical Project Lead
Gert Van Hoey
Expert Software Engineer
Tom Van Quaethem
Hardware Lead
Guillem Vela
Product & Applications Manager
Jonathan Vervaeke
Senior Staff Engineer
Bert Vynckier
Service Engineer
Guido Van der Schueren
Chairman of the Board
Lloyd Diamond
Board Member
Patrick Keereman
Board Member
Walter Mastelinck
Board Member
Bram Decroix
Board Member
Roel Van Holen
Co-Founder & Strategic Advisor
Bodo Wiegand
Strategic Advisor
Bjorn Delbeecke
Strategic Advisor
Gijs Klarenbeek
Strategic Advisor

Subscribe to
our newsletter